Back to search

Article

Peptide derived nanobody inhibits entry of SARS-CoV-2 variants

2022-04-21

Abstract excerpt

Emergence of the new escape mutants of the SARS-CoV-2 virus has escalated its penetration among the human population and has reinstated its status as a global pandemic. Therefore, developing effective antiviral therapy against emerging SARS variants and other viruses in a short period of time becomes essential. Blocking the SARS-CoV-2 entry into human host cells by disrupting the spike glycoprotein-ACE2 interactio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
29d348f3-d7da-5c6f-aff1-4df888fb1dee
DOI
10.1101/2022.04.21.489021
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Peptide derived nanobody inhibits entry of SARS-CoV-2 variantsDOI 10.1101/2022.04.21.489021
Select a neighboring publication to make it the new centre.